BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20103714)

  • 1. Igf-I bioactivity in an elderly population: relation to insulin sensitivity, insulin levels, and the metabolic syndrome.
    Brugts MP; van Duijn CM; Hofland LJ; Witteman JC; Lamberts SW; Janssen JA
    Diabetes; 2010 Feb; 59(2):505-8. PubMed ID: 20103714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term low-dose growth hormone administration in subjects with impaired glucose tolerance and the metabolic syndrome: effects on beta-cell function and post-load glucose tolerance.
    Yuen K; Wareham N; Frystyk J; Hennings S; Mitchell J; Fryklund L; Dunger D
    Eur J Endocrinol; 2004 Jul; 151(1):39-45. PubMed ID: 15248820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.
    Sesti G; Sciacqua A; Cardellini M; Marini MA; Maio R; Vatrano M; Succurro E; Lauro R; Federici M; Perticone F
    Diabetes Care; 2005 Jan; 28(1):120-5. PubMed ID: 15616244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: comparison with five widely used IGF-I immunoassays.
    Brugts MP; Ranke MB; Hofland LJ; van der Wansem K; Weber K; Frystyk J; Lamberts SW; Janssen JA
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2539-45. PubMed ID: 18397983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity.
    Arafat AM; Weickert MO; Frystyk J; Spranger J; Schöfl C; Möhlig M; Pfeiffer AF
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5093-101. PubMed ID: 19846739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients.
    Pouriamehr S; Barmaki H; Rastegary M; Lotfi F; Nabi Afjadi M
    BMC Res Notes; 2019 Oct; 12(1):653. PubMed ID: 31601230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.
    Nóvoa FJ; Boronat M; Saavedra P; Díaz-Cremades JM; Varillas VF; La Roche F; Alberiche MP; Carrillo A
    Diabetes Care; 2005 Oct; 28(10):2388-93. PubMed ID: 16186268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study.
    Sandhu MS; Heald AH; Gibson JM; Cruickshank JK; Dunger DB; Wareham NJ
    Lancet; 2002 May; 359(9319):1740-5. PubMed ID: 12049864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of plasma insulin-like growth factor I (IGF I), IGF II, IGF binding proteins, type 1 IGF receptor and growth hormone binding protein in community-dwelling elderly subjects with no malnutrition and no inflammation.
    Raynaud-Simon A
    J Nutr Health Aging; 2003; 7(4):267-73. PubMed ID: 12917753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum.
    Chen JW; Ledet T; Orskov H; Jessen N; Lund S; Whittaker J; De Meyts P; Larsen MB; Christiansen JS; Frystyk J
    Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1149-55. PubMed ID: 12604504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality.
    Brugts MP; van den Beld AW; Hofland LJ; van der Wansem K; van Koetsveld PM; Frystyk J; Lamberts SW; Janssen JA
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2515-22. PubMed ID: 18413430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults.
    Rajpathak SN; McGinn AP; Strickler HD; Rohan TE; Pollak M; Cappola AR; Kuller L; Xue X; Newman AB; Strotmeyer ES; Psaty BM; Kaplan RC
    Growth Horm IGF Res; 2008 Apr; 18(2):166-73. PubMed ID: 17904401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion.
    Hedman CA; Frystyk J; Lindström T; Oskarsson P; Arnqvist HJ
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):58-62. PubMed ID: 23865977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans.
    Brennan AM; Lee JH; Tsiodras S; Chan JL; Doweiko J; Chimienti SN; Wadhwa SG; Karchmer AW; Mantzoros CS
    Eur J Endocrinol; 2009 Feb; 160(2):173-6. PubMed ID: 19029226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
    Nam SY; Lee EJ; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 1997 May; 21(5):355-9. PubMed ID: 9152736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pure ethanol and alcopops on glucose, insulin, and the insulin-like growth factor system in healthy subjects.
    Grønbaek H; Flyvbjerg A; Winding P; Frystyk J; Hey H
    Growth Horm IGF Res; 2005 Aug; 15(4):243-50. PubMed ID: 15925526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailable IGF-1 and its Relation to the Metabolic Syndrome in a Bi-Ethnic Population of Men and Women.
    Koegelenberg AS; Schutte R; Smith W; Schutte AE
    Horm Metab Res; 2016 Feb; 48(2):130-6. PubMed ID: 26348017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
    J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
    Liang S; Hu Y; Liu C; Qi J; Li G
    Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.